ACN
Recent news mentioning ACN
- — Introducing the Next-Generation LightStim for Wrinkles and LightStim for Acne
- — Can Accenture (ACN) Turn Its AI Strategy Into Sustainable Growth?
- — Accenture (ACN) Positioned to Sustain Its Long-Term Competitive Position
- — PanOxyl® Acne Gel Wash Earns Coveted 2026 Allure Best of Beauty Award
- — Investor Fears of AI Disintermediation Weigh on Accenture (ACN) Stock
- — Lutris Pharma to Present Updated Data from Its Phase 2 Trial of LUT014 Gel for the Treatment of Patients With EGFRI-Induced Acneiform Rash at the EADV Congress
- — Inside Broyhill’s Bearish Exit of Accenture (ACN)
- — Chicago Faucets Joins BACnet International, Bringing Point-of-Use Water Data to Building Automation Systems
- — TCL umacnia swoją pozycję na rynku smartfonów, prezentując serię P80 na targach IFA 2026
- — Qapture Investments Establishes Investment Manager and Acquires Hermetik Trading's DeFi Strategies; Appoints Brendan MacNeil as Head of DeFi
- — Accenture Stock: Is ACN Underperforming the Technology Sector?
- — Biosidus zwiększa moce produkcyjne w zakresie leków biologicznych i wzmacnia globalne możliwości dostaw agalzydazy beta